Views & Analysis Access and elimination: the future of DAAs in hepatitis C How direct-acting antivirals are transforming treatment of hepatitis C.
News UK sets 2029 timeline to end Palantir's NHS contract The UK government has said it will end the NHS's controversial contract with US tech firm Palantir, but not until 2029.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.